PharmaCielo Names David Gordon as Chief Corporate Officer

Toronto-based medical marijuana company PharmaCielo Ltd. has named David Gordon as its new chief corporate officer.

Gordon, former managing partner in Canada for global public relations firm Cohn & Wolfe, will formally step into the role on October 1.

Photo: David Gordon will take over as chief corporate Officer of PharmaCielo on October 1. (Photo credit: CNW Group/PharmaCielo)

The company said in a statement that the incoming executive has previously served as an “essential advisor” to PharmaCielo and will now be charged with managing relations with stakeholders, regulators, and the press as well as overseeing development plans overseas.

Company subsidiary PharmaCielo Colombia Holdings S.A.S. is based in Rionegro, Colombia, and has been the centerpiece of the firm’s plans for growth in the country’s medical marijuana sector.

The company has been developing its nursery and harvest in the Antioquia city in recent years as it has navigated the regulatory requirements in the still-emerging industry following nationwide legalization for medical cannabis in late 2016.

“The emergence of a new industry that challenges convention on multiple levels — including international trade, public policy and communication to name but a few — encapsulates the various fields of challenge I have experienced throughout my career,” said David Gordon.

“I look forward to continuing to work with my colleagues in Canada and Colombia to help expand to the global market the leadership that PharmaCielo has demonstrated in the Colombian marketplace.”